Defendant Name: Elanco Animal Health Inc.

Defendant Type: Public Company
SIC Code: 2834
CUSIP: 28414H10

Document Reference: 33-11326

Document Details

Legal Case Name In the Matter of Elanco Animal Health Inc.
Document Name Order Instituting Cease-and-Desist Proceedings Pursuant to Section 8A of the Securities Act of 1933 and Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
Document Date 12-Nov-2024
Document Format Administrative Proceeding
File Number 3-22309
Allegation Type Issuer Reporting and Disclosure
Document Summary On November 12, 2024, the SEC instituted settled cease-and-desist proceedings against Elanco Animal Health Inc., stating: "This matter concerns Elanco’s failure to disclose material information concerning its sales practices that rendered statements it made about its revenue growth misleading."

Disgorgement & Penalty Information

Resolutions
Cease and Desist Order
Remedial Acts or Efforts Before the Resolution
Fair Funds
Monetary Penalties:

Civil Penalty

Individual:     $15,000,000.00 Shared:    

Related Documents:

33-11326-s 12-Nov-2024 Administrative Summary
SEC Charges Indiana-Based Animal Health Products Company with Antifraud Violations
On November 12, 2024, the SEC "announced antifraud charges against Elanco Animal Health Inc. for misleading investors when it made statements about its revenue growth and end-user demand without also disclosing its reliance on certain quarter-end sales incentives that were necessary to achieve that revenue and caused its distributors to purchase goods in excess of existing end user demand. Elanco has agreed to pay $15 million to settle the charges."